These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 141818)

  • 1. [Spontaneous leukemia of AKR mice. Successful passive immunization with goat antibodies against isolated glycoprotein gp71 of Friend leukemia virus].
    Schwarz H; Thiel HJ; Schäfer W
    Z Naturforsch C Biosci; 1977; 32(5-6):459-61. PubMed ID: 141818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum.
    Hunsmann G; Moennig V; Schäfer W
    Virology; 1975 Jul; 66(1):327-9. PubMed ID: 1136142
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71.
    Schwarz H; Ihle JN; Wecker E; Fischinger PJ; Thiel HJ; Bolognesi DP; Schäfer W
    Virology; 1981 Jun; 111(2):568-78. PubMed ID: 6264673
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of spontaneous leukemia in AKR mice by passive immunization and type specificity of this protection.
    Fish DC; Gilden RV; Bare RM; Trimmer RM; Huebner RJ
    J Natl Cancer Inst; 1979 Apr; 62(4):943-5. PubMed ID: 219284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of spontaneous leukemia in AKR mice by type-specific immunosuppression of endogenous ecotropic virogenes.
    Huebner RJ; Gilden RV; Toni R; Hill RW; Trimmer RW; Fish DC; Sass B
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4633-5. PubMed ID: 188047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bone marrow and thymic elements in the initiation and spread of virus production in the AKR thymus.
    Buckheit RW; Bolognesi DP; Weinhold KJ
    Virology; 1988 Oct; 166(2):533-41. PubMed ID: 3176345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of mouse leukemia viruses. XVI. Suppression of spontaneous fetal leukemias in AKR mice by treatment with broadly reacting antibody against the viral glycoprotein gp 71.
    Schwarz H; Fischinger PJ; Ihle JN; Thiel HJ; Weiland F; Bolognesi DP; Schäfer W
    Virology; 1979 Feb; 93(1):159-74. PubMed ID: 433151
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protection of mice against Friend leukemia by active and passive immunization with isolated viral glycoprotein and its antiserum respectively (author's transl)].
    Hunsmann G; Moennig V; Seifert E; Schäfer W
    Z Naturforsch C Biosci; 1975; 30(2):309-10. PubMed ID: 125981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on the surfaces of normal murine cells.
    Cloyd MW; Bolognesi DP; Bigner DD
    Cancer Res; 1977 Mar; 37(3):931-8. PubMed ID: 65220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
    Genovesi EV; Collins JJ
    J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in Friend virus leukemia. II. Prevention of friend leukemia by passive administration of immune serum and cells to young mice.
    Wahren B
    J Natl Cancer Inst; 1968 Oct; 41(4):931-8. PubMed ID: 5693664
    [No Abstract]   [Full Text] [Related]  

  • 12. Properties of mouse leukemia viruses: XX. Variation of AKR Substrains in response to antibody therapy.
    Schwarz H; Thiel HJ; Weinhold K; Fischinger P; Bolognesi D; Schäfer W
    Virology; 1986 Apr; 150(1):247-51. PubMed ID: 3952985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. III. Influence on endogenous MuLV-mediated pathogenesis.
    Ihle JN; Collins JJ; Lee JC; Fischinger PJ; Pazmino N; Moennig V; Schäfer W; Hanna MG; Bolognesi DP
    Virology; 1976 Nov; 75(1):102-12. PubMed ID: 982843
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy in Friend virus leukemia. I. Prevention of Friend leukemia in the offspring of immunized mothers.
    Wahren B
    J Natl Cancer Inst; 1968 Oct; 41(4):923-9. PubMed ID: 5693663
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus.
    Fischinger PJ; Sch5AAFER W; Bolognesi DP
    Virology; 1976 May; 71(1):169-84. PubMed ID: 58469
    [No Abstract]   [Full Text] [Related]  

  • 16. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus.
    Lee JC; Ihle JN; Huebner R
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):343-7. PubMed ID: 189311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on surfaces of virus-producing murine and other mammalian species cell lines.
    Cloyd MW; Bolognesi DP; Bigner DD
    Cancer Res; 1977 Mar; 37(3):922-30. PubMed ID: 65219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease.
    Collins JJ; Sackie DM; Johnson GR
    Virology; 1983 Apr; 126(1):259-66. PubMed ID: 6573816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of mouse leukemia viruses. XIII. Serum therapy of virus-induced murine leukemias.
    Schäfer W; Schwarz H; Thiel HJ; Wecker E; Bolognesi DP
    Virology; 1976 Dec; 75(2):401-18. PubMed ID: 795137
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
    Sanfilippo F; Genovesi EV; Collins JJ
    J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.